A1M Pharma AB logo

A1M TO - A1M Pharma AB Share Price

SEK0.156 -0.1  -33.9%

Last Trade - 5:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £12.4m
Enterprise Value £8.27m
Revenue £n/a
Position in Universe 1196th / 1491
Bullish
Bearish
Unlock A1M TO Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

A1M TO Revenue Unlock A1M TO Revenue

Net Income

A1M TO Net Income Unlock A1M TO Revenue

Normalised EPS

A1M TO Normalised EPS Unlock A1M TO Revenue

PE Ratio Range

A1M TO PE Ratio Range Unlock A1M TO Revenue

Dividend Yield Range

A1M TO Dividend Yield Range Unlock A1M TO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
A1M TO EPS Forecasts Unlock A1M TO Revenue
Profile Summary

A1M Pharma AB is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated April 4, 2008
Public Since April 3, 2013
No. of Shareholders: n/a
No. of Employees: 14
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm (Dual Listing)
Shares in Issue 129,667,745
Free Float (0.0%)
Eligible for
ISAs
SIPPs
A1M TO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to A1M TO
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.